(Q38023821)

27 August 2017

Health status of ayahuasca users (English)

1 reference

27 August 2017

1 reference

3

Michael P Bogenschutz

0 references

author name string

Paulo Cesar Ribeiro Barbosa

series ordinal

1

1 reference

PubMed ID

22761152

27 August 2017

Suely Mizumoto

series ordinal

2

1 reference

PubMed ID

22761152

27 August 2017

Rick J Strassman

series ordinal

4

1 reference

27 August 2017

4 July 2012

1 reference

Drug Testing and Analysis

27 August 2017

1 reference

27 August 2017

4

1 reference

27 August 2017

7-8

1 reference

27 August 2017

601-609

1 reference

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca

27 August 2017

1 reference

Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.

21 January 2018

1 reference

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

21 January 2018

1 reference

Bringing ayahuasca to the clinical research laboratory.

21 January 2018

1 reference

Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil

21 January 2018

1 reference

Changes in spirituality among ayahuasca ceremony novice participants.

21 January 2018

1 reference

Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca

21 January 2018

1 reference

Pharmacokinetics of Hoasca alkaloids in healthy humans

21 January 2018

1 reference

Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca

21 January 2018

1 reference

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

21 January 2018

1 reference

A modern-day shamanistic healer in the Peruvian Amazon: pharmacopoeia and trance

21 January 2018

1 reference

The globalization of ayahuasca: harm reduction or benefit maximization?

21 January 2018

1 reference

Ayahuasca healing beyond the Amazon: the globalization of a traditional indigenous entheogenic practice

21 January 2018

1 reference

The "vine of the soul" vs. the Controlled Substances Act: implications of the hoasca case

21 January 2018

1 reference

Report on psychoactive drug use among adolescents using ayahuasca within a religious context

21 January 2018

1 reference

Assessment of addiction severity among ritual users of ayahuasca

21 January 2018

1 reference

Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users

21 January 2018

1 reference

Ayahuasca in adolescence: a preliminary psychiatric assessment

21 January 2018

1 reference

A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects

21 January 2018

1 reference

Ayahuasca in adolescence: a neuropsychological assessment.

21 January 2018

1 reference

Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.

21 January 2018

1 reference

Platelet serotonin uptake sites increased in drinkers of ayahuasca

21 January 2018

1 reference

Drug tourism or spiritual healing? Ayahuasca seekers in Amazonia.

21 January 2018

1 reference

Experiences of encounters with ayahuasca--"the vine of the soul".

21 January 2018

1 reference

Ayahuasca in adolescence: Qaualitative results

21 January 2018

1 reference

Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges

21 January 2018

1 reference

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.

21 January 2018

1 reference

Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus.

21 January 2018

1 reference

Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties

21 January 2018

1 reference

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

21 January 2018

1 reference

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

21 January 2018

1 reference

21 January 2018

Psychedelic sacraments

1 reference

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

21 January 2018

1 reference

Human hallucinogen research: guidelines for safety

21 January 2018

1 reference

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

21 January 2018

1 reference

Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions

21 January 2018

1 reference

Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry

21 January 2018

1 reference

Drug use and abuse in cross cultural perspective.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

The Hallucinogenic Drugs—Curse or Blessing?

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DTA.1383

1 reference

27 August 2017

1 reference

PubMed ID

22761152